EFFECTIVENESS AND COST-EFFECTIVENESS OF TRIPLE THERAPY WITH TELAPREVIR AND BOCEPREVIR FOR CHRONIC HEPATITIS C: A DECISION ANALYSIS FROM THE PERSPECTIVE OF THE BRAZILIAN PUBLIC HEALTH SYSTEM

被引：0
|
作者：
Borba, H. H. [1 ]
Rochau, U. [2 ]
Wiens, A. [1 ]
Sroczynski, G. [2 ]
Siebert, U. [3 ]
Pontarolo, R. [1 ]
机构：
[1] Univ Fed Parana, Curitiba, Parana, Brazil
[2] UMIT Univ Hlth Sci Med Informat & Technol, Inst Publ Hlth Med Decis Making & HTA, Dept Publ Hlth Hlth Serv Res & HTA, Hall In Tirol, Austria
[3] UMIT Univ Hlth Sci Med Informat & Technol, Dept Publ Hlth Hlth Serv Res & Hlth Technol Asses, Hall In Tirol, Austria
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.2627
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PGI9
引用
收藏
页码：A883 / A883
页数：1
相关论文
共 50 条
  • [11] Cost-effectiveness of insulin analogs from the perspective of the Brazilian public health system
    Cazarim, Maurilio de Souza
    Vilela Rodrigues, Joao Paulo
    Coelho da Cruz-Cazarim, Estael Luzia
    Ayres, Lorena Rocha
    Leira Pereira, Leonardo Regis
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 53 (03)
  • [12] Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C
    Petta, Salvatore
    Cabibbo, Giuseppe
    Enea, Marco
    Macaluso, Fabio Salvatore
    Plaia, Antonella
    Bruno, Raffaele
    Gasbarrini, Antonio
    Bruno, Savino
    Craxi, Antonio
    Camma, Calogero
    DIGESTIVE AND LIVER DISEASE, 2014, 46 (10) : 936 - 942
  • [13] The Real Life Effectiveness of Telaprevir Triple Therapy in Chronic Hepatitis C
    Al-Bawardy, Badr
    Kim, W. Ray
    Poterucha, John
    Charlton, Michael
    Canterbury, Katherine
    Gross, John
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S170 - S170
  • [14] COST-EFFECTIVENESS OF BOCEPREVIR THERAPY IN ADULT PATIENTS WITH CHRONIC HEPATITIS C (HCV) GENOTYPE 1
    Mernagh, P.
    Feng, J.
    Del Cuore, M.
    VALUE IN HEALTH, 2013, 16 (03) : A94 - A94
  • [15] COST-EFFECTIVENESS OF BOCEPREVIR IN THE TREATMENT OF CHRONIC HEPATITIS C GENOTYPE 1 IN SWEDEN
    Chhatwal, J.
    Lundberg, J.
    Ferrante, S.
    El Khourhy, A. C.
    Oksanen, A.
    Elbasha, E. H.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S386 - S387
  • [16] Therapy of hepatitis C: Cost-effectiveness analysis
    Koff, RS
    HEPATOLOGY, 1997, 26 (03) : S152 - S155
  • [17] COST-EFFECTIVENESS OF TRIPLE THERAPY WITH TELAPREVIR FOR THE TREATMENT OF TREATMENT-NAIVE GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS IN GERMANY
    Stahmeyer, J. T.
    Schauer, S.
    Wirth, D.
    Fleischmann, J.
    Lee, S.
    Gavart, S.
    Bianic, F.
    Cure, S.
    Krauth, C.
    VALUE IN HEALTH, 2012, 15 (07) : A396 - A396
  • [18] Effectiveness of Telaprevir and Boceprevir Triple Therapy for Patients with Hepatitis C Virus Infection in a Large Integrated Care Setting
    Jennifer C. Price
    Rosemary C. Murphy
    Valentina A. Shvachko
    Mary Pat Pauly
    M. Michele Manos
    Digestive Diseases and Sciences, 2014, 59 : 3043 - 3052
  • [19] Boceprevir for Chronic Genotype 1 Hepatitis C Virus in the Current Health Care Setting in Greece: A Cost-effectiveness Analysis
    Athanasakis, Kostas
    Ferrante, Shannon Allen
    Kyriopoulos, Ilias-Loannis
    Petrakis, Ioannis
    Hill, Mary
    Retsa, Maria-Pagona
    Kyriopoulos, John
    CLINICAL THERAPEUTICS, 2015, 37 (07) : 1529 - 1540
  • [20] Effectiveness of Telaprevir and Boceprevir Triple Therapy for Patients with Hepatitis C Virus Infection in a Large Integrated Care Setting
    Price, Jennifer C.
    Murphy, Rosemary C.
    Shvachko, Valentina A.
    Pauly, Mary Pat
    Manos, M. Michele
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (12) : 3043 - 3052
12345